Candel Therapeutics Closes Securities Offering to Raise $92 Million

MT Newswires Live

2024/12/17

Candel Therapeutics (CADL) closed an offering of 12 million shares at $6 apiece and prefunded warrants to raise $92 million in gross proceed.

The warrants are for purchasing up to 3.33 million shares at $5.99 per prefunded warrant to purchase one share of common stock, the company said late Monday in a statement.

The sale includes 2 million shares sold following the full exercise of the underwriters' option.

Candel intends to use the net proceeds to continue the development of its product candidates, including preparing the submission of a biologics license application for CAN-2409 in prostate cancer.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2492624336"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2492624336\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2492624336?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-17 06:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492624336","market":"nz","top_or_hot":-1,"title":"Candel Therapeutics Closes Securities Offering to Raise $92 Million","media":"MT Newswires Live","content":"<html><body><p> Candel <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (CADL) closed an offering of 12 million shares at $6 apiece and prefunded warrants to raise $92 million in gross proceed.</p><p>The warrants are for purchasing up to 3.33 million shares at $5.99 per prefunded warrant to purchase one share of common stock, the company said late Monday in a statement.</p><p>The sale includes 2 million shares sold following the full exercise of the underwriters' option.</p><p>Candel intends to use the net proceeds to continue the development of its product candidates, including preparing the submission of a biologics license application for CAN-2409 in prostate cancer.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Candel Therapeutics Closes Securities Offering to Raise $92 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCandel Therapeutics Closes Securities Offering to Raise $92 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-12-17 06:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Candel <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (CADL) closed an offering of 12 million shares at $6 apiece and prefunded warrants to raise $92 million in gross proceed.</p><p>The warrants are for purchasing up to 3.33 million shares at $5.99 per prefunded warrant to purchase one share of common stock, the company said late Monday in a statement.</p><p>The sale includes 2 million shares sold following the full exercise of the underwriters' option.</p><p>Candel intends to use the net proceeds to continue the development of its product candidates, including preparing the submission of a biologics license application for CAN-2409 in prostate cancer.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CADL","symbol_name":"Candel Therapeutics, Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2492624336","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492624336","pubTimestamp":1734389710,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Candel Therapeutics  closed an offering of 12 million shares at $6 apiece and prefunded warrants to raise $92 million in gross proceed.The warrants are for purchasing up to 3.33 million shares at $5.99 per prefunded warrant to purchase one share of common stock, the company said late Monday in a statement.The sale includes 2 million shares sold following the full exercise of the underwriters' option.Candel intends to use the net proceeds to continue the development of its product candidates, including preparing the submission of a biologics license application for CAN-2409 in prostate cancer.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CADL":"Candel Therapeutics, Inc.","BK4139":"生物科技","BK4539":"次新股","LENZ":"Therapeutics"},"translate_title":"Candel Therapeutics完成证券发行，筹集9200万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CADL":1,"LENZ":1},"content_text":"Candel Therapeutics (CADL) closed an offering of 12 million shares at $6 apiece and prefunded warrants to raise $92 million in gross proceed.The warrants are for purchasing up to 3.33 million shares at $5.99 per prefunded warrant to purchase one share of common stock, the company said late Monday in a statement.The sale includes 2 million shares sold following the full exercise of the underwriters' option.Candel intends to use the net proceeds to continue the development of its product candidates, including preparing the submission of a biologics license application for CAN-2409 in prostate cancer.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}